Visible-light-driven sulfonylation/cyclization of N-methacryloyl-2-phenylbenzoimidazoles has been successfully developed. Using commercially available sulfonyl chloride as sulfonylation reagent, a wide range of sulfonylated benzo[4,5]imidazo[2,1-a]isoquinolin-6(5H)-ones with potential antitumor activity were provided in acceptable to excellent yields. This method has the advantages of mild reaction conditions and outstanding functional group tolerance, and provides a new strategy for the development of potential antitumor lead compounds.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/asia.202100681 | DOI Listing |
Publication Analysis
Top Keywords
visible-light-driven sulfonylation/cyclization
8
sulfonylated benzo[45]imidazo[21-a]isoquinolin-65h-ones
8
potential antitumor
8
sulfonylation/cyclization access
4
access sulfonylated
4
benzo[45]imidazo[21-a]isoquinolin-65h-ones visible-light-driven
4
sulfonylation/cyclization n-methacryloyl-2-phenylbenzoimidazoles
4
n-methacryloyl-2-phenylbenzoimidazoles developed
4
developed commercially
4
commercially sulfonyl
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!